FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3010906827> ?p ?o ?g. }

• W3010906827 endingPage "1760" @default.
• W3010906827 startingPage "1760" @default.
• W3010906827 abstract "Stroke is a leading cause of death worldwide. The cases of acute ischemic stroke are on the increase in the Asia Pacific, particularly in Malaysia. Various health organizations have recommended guidelines for managing ischemic stroke, but adherence to key performance indicators (KPI) from the guidelines and impact on patient outcomes, particularly mortality, are rarely explored.This study aims to evaluate the impact of adherence to key performance indicators on mortality among patients managed for ischemic stroke.We included all first-ever ischemic stroke patients enrolled in the multiethnic Malaysian National Neurology Registry (NNeuR) - a prospective cohort study and followed-up for six months. Patients' baseline clinical characteristics, risk factors, neurological findings, treatments, KPI and mortality outcome were evaluated. The KPI nonadherence (NAR) and relationship with mortality were evaluated. NAR>25% threshold was considered suboptimal.A total of 579 first-ever ischemic stroke patients were included in the final analysis. The overall mortality was recorded as 23 (4.0%) in six months, with a median (interquartile) age of 65 (20) years. Majority of the patients (dead or alive) had partial anterior circulation infarct, PACI (43.5%; 34.0%) and total anterior circulation infarct, TACI (26.1%; 8.8%). In addition, DVT prophylaxis (82.8%), anticoagulant for atrial fibrillation (AF) patients (48.8%) and rehabilitation (26.2%) were considered suboptimal. NAR < 2 was significantly associated with a decrease in mortality (odds ratio 0.16; 0.02-0.12) compared to NAR>2. Survival analysis showed that death is more likely in patients with NAR>2 (p=0.05).KPI nonadherence was associated with mortality among ischemic stroke patients. The adherence to the KPI was sub-optimal, particularly in DVT prophylaxis, anticoagulant for AF patients and rehabilitation. These findings reflect the importance of continuous quality measurement and implementation of evidence recommendations in healthcare delivery to achieve optimal outcome among stroke patients." @default.
• W3010906827 created "2020-03-23" @default.
• W3010906827 creator A5004498400 @default.
• W3010906827 creator A5008810716 @default.
• W3010906827 creator A5014598869 @default.
• W3010906827 creator A5022540095 @default.
• W3010906827 creator A5032626475 @default.
• W3010906827 creator A5043688060 @default.
• W3010906827 creator A5080266936 @default.
• W3010906827 creator A5090109714 @default.
• W3010906827 creator A5091638121 @default.
• W3010906827 date "2020-03-31" @default.
• W3010906827 modified "2023-09-23" @default.
• W3010906827 title "Impact of adherence to key performance indicators on mortality among patients managed for ischemic stroke" @default.
• W3010906827 cites W1220714092 @default.
• W3010906827 cites W1480729244 @default.
• W3010906827 cites W1571608876 @default.
• W3010906827 cites W163371252 @default.
• W3010906827 cites W1973457515 @default.
• W3010906827 cites W1987675314 @default.
• W3010906827 cites W2014042145 @default.
• W3010906827 cites W2021278051 @default.
• W3010906827 cites W2061501167 @default.
• W3010906827 cites W2072396058 @default.
• W3010906827 cites W2074979738 @default.
• W3010906827 cites W2093452916 @default.
• W3010906827 cites W2093814225 @default.
• W3010906827 cites W2095955991 @default.
• W3010906827 cites W2098859227 @default.
• W3010906827 cites W2103048988 @default.
• W3010906827 cites W2107876763 @default.
• W3010906827 cites W2112053679 @default.
• W3010906827 cites W2116656725 @default.
• W3010906827 cites W2119294004 @default.
• W3010906827 cites W2120169047 @default.
• W3010906827 cites W2121158877 @default.
• W3010906827 cites W2124247204 @default.
• W3010906827 cites W2143566210 @default.
• W3010906827 cites W2152373758 @default.
• W3010906827 cites W2161325913 @default.
• W3010906827 cites W2164611094 @default.
• W3010906827 cites W2171165037 @default.
• W3010906827 cites W2196894528 @default.
• W3010906827 cites W2416936815 @default.
• W3010906827 cites W2763594220 @default.
• W3010906827 cites W2769635641 @default.
• W3010906827 cites W2788451337 @default.
• W3010906827 cites W2795481792 @default.
• W3010906827 cites W2803306216 @default.
• W3010906827 cites W2808133395 @default.
• W3010906827 cites W2883983259 @default.
• W3010906827 cites W2897193877 @default.
• W3010906827 cites W2898947659 @default.
• W3010906827 cites W2905512463 @default.
• W3010906827 cites W2913705661 @default.
• W3010906827 cites W2921112006 @default.
• W3010906827 cites W2998714532 @default.
• W3010906827 cites W3157419554 @default.
• W3010906827 cites W4299693136 @default.
• W3010906827 doi "https://doi.org/10.18549/pharmpract.2020.1.1760" @default.
• W3010906827 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7092711" @default.
• W3010906827 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32256900" @default.
• W3010906827 hasPublicationYear "2020" @default.
• W3010906827 type Work @default.
• W3010906827 sameAs 3010906827 @default.
• W3010906827 citedByCount "1" @default.
• W3010906827 countsByYear W30109068272022 @default.
• W3010906827 crossrefType "journal-article" @default.
• W3010906827 hasAuthorship W3010906827A5004498400 @default.
• W3010906827 hasAuthorship W3010906827A5008810716 @default.
• W3010906827 hasAuthorship W3010906827A5014598869 @default.
• W3010906827 hasAuthorship W3010906827A5022540095 @default.
• W3010906827 hasAuthorship W3010906827A5032626475 @default.
• W3010906827 hasAuthorship W3010906827A5043688060 @default.
• W3010906827 hasAuthorship W3010906827A5080266936 @default.
• W3010906827 hasAuthorship W3010906827A5090109714 @default.
• W3010906827 hasAuthorship W3010906827A5091638121 @default.
• W3010906827 hasBestOaLocation W30109068271 @default.
• W3010906827 hasConcept C119060515 @default.
• W3010906827 hasConcept C126322002 @default.
• W3010906827 hasConcept C127413603 @default.
• W3010906827 hasConcept C156957248 @default.
• W3010906827 hasConcept C1862650 @default.
• W3010906827 hasConcept C2778818304 @default.
• W3010906827 hasConcept C2779134260 @default.
• W3010906827 hasConcept C2779161974 @default.
• W3010906827 hasConcept C2780645631 @default.
• W3010906827 hasConcept C29374701 @default.
• W3010906827 hasConcept C71924100 @default.
• W3010906827 hasConcept C72563966 @default.
• W3010906827 hasConcept C78519656 @default.
• W3010906827 hasConceptScore W3010906827C119060515 @default.
• W3010906827 hasConceptScore W3010906827C126322002 @default.
• W3010906827 hasConceptScore W3010906827C127413603 @default.
• W3010906827 hasConceptScore W3010906827C156957248 @default.
• W3010906827 hasConceptScore W3010906827C1862650 @default.
• W3010906827 hasConceptScore W3010906827C2778818304 @default.
• W3010906827 hasConceptScore W3010906827C2779134260 @default.

• next